α‐synuclein pathology drives region‐specific tau deposition
Alzheimer's & Dementia · 2026-10 · 22 (10)
DOI: 10.1002/alz.71932 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 25.10.2026. Verfasst von Seyed Hani Hojjati und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Brain Health Imaging Institute, Weill Cornell Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: tau Proteins, alpha-Synuclein, Lewy Body Disease, Brain. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
INTRODUCTION Dementia with Lewy bodies (DLB) is a common but underdiagnosed neurodegenerative disease associated with α‐synuclein pathology. Clinically, DLB is characterized by early motor dysfunction and psychiatric symptoms, in contrast to early memory decline typical of Alzheimer's disease (AD). Lewy body and AD pathology commonly co‐occur. It remains unclear how α‐synuclein pathology, either alone or in combination with AD pathology, produces clinical features considered distinctive of synucleinopathy. METHODS We analyzed 531 Alzheimer's Disease Neuroimaging Initiative participants using neuroimaging to compare tau deposition patterns between α‐synuclein–positive and α‐synuclein–negative individuals. RESULTS α‐synuclein–positive individuals showed significantly greater tau deposition in basal ganglia (BG), insula, and medial temporal lobe (MTL). Increased tau burden in these regions correlated with more severe psychiatric symptoms and slower reaction times. These associations were present only in the α‐synuclein–positive group. DISCUSSION These results suggest that α‐synuclein pathology is associated with region‐specific tau positron emission tomography abnormalities that map onto core clinical features of synucleinopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Brain Health Imaging Institute, Weill Cornell Medicine, New York, New York, USA.
ORCID-Profile: Seyed Hani Hojjati
Förderung
- NIA NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Hojjati, S. H., Chiang, G. C., Wang, X. H., Khalafi, M., Shah, S., Zhou, L., Keil, S., Glodzik, L., McIntire, L. B. J., Tanzi, E., Feiz, F., Maloney, T., Li, Y., Butler, T. A., & Alzheimer's Disease Neuroimaging Initiative (2026). α‐synuclein pathology drives region‐specific tau deposition. Alzheimer's & Dementia, 22(10). https://doi.org/10.1002/alz.71932
Vancouver
Hojjati SH, Chiang GC, Wang XH, Khalafi M, Shah S, Zhou L, et al. α‐synuclein pathology drives region‐specific tau deposition. Alzheimer's & Dementia. 2026;22(10). doi:10.1002/alz.71932
BibTeX
@article{Hojjati2026,
author = {Hojjati, Seyed Hani and Chiang, Gloria C and Wang, Xiuyuan Hugh and Khalafi, Mohammad and Shah, Sudhin and Zhou, Liangdong and Keil, Samantha and Glodzik, Lidia and McIntire, Laura Beth J and Tanzi, Emily and Feiz, Farnia and Maloney, Tom and Li, Yi and Butler, Tracy A and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {α‐synuclein pathology drives region‐specific tau deposition},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {10},
doi = {10.1002/alz.71932}
}
EUVIMED